cancer

Systemic delivery of gemcitabine analogue and STAT3 siRNA promotes antitumor immunity against melanoma

Learn More

Stromal AR inhibits prostate tumor progression by restraining secretory luminal epithelial cells

Learn More

Plasma aromatase activity index, gonadotropins and estrone are associated with frailty syndrome in post-menopausal women with breast cancer

Learn More

Hypoxia enhances HIF1α transcription activity by upregulating KDM4A and mediating H3K9me3, thus inducing ferroptosis resistance in cervical cancer cells

Learn More

The endocrine disruptor compound bisphenol-A (BPA) regulates the intra-tumoral immune microenvironment and increases lung metastasis in an experimental model of breast cancer

Learn More

Membrane progesterone receptor α (mPRα) enhances hypoxia-induced vascular endothelial growth factor secretion and angiogenesis in lung adenocarcinoma through STAT3 signaling

Learn More

Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways

Learn More

Safety profile of rapamycin perfluorocarbon nanoparticles for preventing cisplatin-induced kidney injury

Learn More

Cancer Biomarkers

Learn More

Microglia in the hypothalamus respond to tumor‐derived factors and are protective against cachexia during pancreatic cancer

Learn More

Dietary AGEs involvement in colonic inflammation and cancer: insights from an in vitro enterocyte model

Learn More

Reprogramming of ovarian granulosa cells by YAP1 leads to development of high-grade cancer with mesenchymal lineage and serous features

Learn More